Contraception clinical trials at UC Davis
2 research studies open to eligible people
Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)
“We're looking for women who have been using Nexplanon for 2-1/2 to 3 years and want to continuing using the implant for a total of 5 years”
open to eligible females ages up to 35 years
The primary purpose of this study is to assess the efficacy and safety of the etonogestrel (ENG) contraceptive implant during participants' fourth and fifth years of use when used as the only method of contraception. The ENG implant is currently approved for a 3-year duration, and this study aims to confirm available evidence suggesting that the ENG implant remains highly effective when used up to 5 years.
Sacramento, California and other locations
Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive
“Join a study that aims to improve how well your birth control works at preventing pregnancy!”
open to eligible females ages 18 years and up
Women currently using or starting a combined oral contraceptive (COC) will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for approximately 12 months to evaluate if they continue the implant, the COC, or both, and to assess bleeding patterns and adverse events.
Sacramento, California and other locations
Our lead scientists for Contraception research studies include Melissa C Matulich, MD MAS.
Last updated: